Classification and Statistical Trend Analysis in Detecting Glaucomatous Visual Field Progression

Abstract EN

Aim.

To evaluate the agreement between different methods in detection of glaucomatous visual field progression using two classification-based methods and four statistical approaches based on trend analysis.

Methods.

This is a retrospective and longitudinal study.

Twenty Caucasian patients (mean age 73.8 ± 13.43 years) with open-angle glaucoma were recruited in the study.

Each visual field was assessed by Humphrey Field Analyzer, program SITA standard 30-2 or 24-2 (Carl Zeiss Meditec, Inc., Dublin, CA).

Full threshold strategy was also accepted for baseline tests.

Progression was analyzed by using Hodapp–Parrish–Anderson classification and the Advanced Glaucoma Intervention Study visual field defect score.

For the statistical analysis, linear regression (r2) was calculated for mean deviation (MD), pattern standard deviation (PSD), and visual field index (VFI), and when it was significant, each series of visual field was considered progressive.

We also used Progressor to look for a significant progression of each visual field series.

The agreement between methods, based on statistical analysis and classification, was evaluated using a weighted kappa statistic.

Results.

Thirty-eight visual field series were analyzed.

The mean follow-up time was 6.2 ± 1.53 years (mean ± standard deviation).

At baseline, the mean MD was −7.34 ± 7.18 dB; at the end of the follow-up, the mean MD was −9.25 ± 8.65 dB; this difference was statistically significant (p<0.001).

The agreement to detect progression was fair between all methods based on statistical analysis and classification except for PSD r2.

A substantial agreement (κ = 0.698 ± 0.126) was found between MD r2 and VFI r2.

With the use of all the statistical analysis, there was a better time-saving.

Conclusions.

The best agreement to detect progression was found between MD r2 and VFI r2.

VFI r2 showed the best agreement with all the other methods.

GPA2 can help ophthalmologists to detect glaucoma progression and to help in treatment decisions.

PSD r2 was the worse method to detect progression.